Midomafetamine for adjustment disorders

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 13 Jul 2022: Trial registered, NCT05455996

The trials

NCT05455996: MDMA-Assisted Therapy for Stress Disorders in Healthcare Workers and First Responders

State
Not started
Phase
Phase 2
People
30 planned
Started
Oct 2026
Primary completion
Jan 2028
Arms
MDMA-assisted therapy
Results
None posted
  1. 13 Jul 2022: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Also known as 3,4 Methylenedioxymethamphetamine, 3,4-Methylenedioxymethamphetamine (MDMA), 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxymethamphetamine (125 mg), Active Dose 1 (125 mg) MDMA HCl, Active Dose 2 (100 mg) MDMA HCl, Full Dose MDMA, Full Dose MDMA-assisted therapy (125 mg), Full dose MDMA-assisted therapy, Mdma, MDMA assisted psychotherapy, Open-Label Full Dose MDMA-assisted therapy (125 mg), methylenedioxymethamphetamine.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.